Equity Overview
Price & Market Data
Price: $0.291
Daily Change: -$0.0035 / 1.20%
Range: $0.282 - $0.299
Market Cap: $8,375,630
Volume: 12,087
Performance Metrics
1 Week: -2.87%
1 Month: 47.15%
3 Months: -28.36%
6 Months: -71.70%
1 Year: -87.20%
YTD: -67.66%
Company Details
Employees: 57
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.